BioNTech counts on shift to cancer drugs after second quarter losses quadruple
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
LOSSES at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday (Aug ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday (Apr 25), accusing them of infringing GSK patents related ...
Philippe legrain says more information is needed on minority businessesOPENCast your mind back to the darkest days of 2020. Covid-19 ...
Moderna on Friday announced in a press release it was suing Pfizer and BioNTech for patent infringement over intellectual property ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.